Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10853649rdf:typepubmed:Citationlld:pubmed
pubmed-article:10853649lifeskim:mentionsumls-concept:C0080194lld:lifeskim
pubmed-article:10853649lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:10853649lifeskim:mentionsumls-concept:C0040557lld:lifeskim
pubmed-article:10853649lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:10853649lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:10853649lifeskim:mentionsumls-concept:C1520022lld:lifeskim
pubmed-article:10853649lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:10853649pubmed:issue9lld:pubmed
pubmed-article:10853649pubmed:dateCreated2000-11-15lld:pubmed
pubmed-article:10853649pubmed:abstractText2-methylfuro[2,3-g]isoquinoline-4,7,9-trione (4) and 2-methylfuro[3,2-g]isoquinoline-4,6,9-trione (5) were prepared regiospecifically from 2-azadiene 9 and bromobenzofuran-4,7-diones 1 or 11. The activity of these two compounds and some other quinonic derivatives was evaluated in vitro against a virulent strain of Toxoplasma gondii. Compounds 4 and 7 were found to be as active as pyrimethamine.lld:pubmed
pubmed-article:10853649pubmed:languageenglld:pubmed
pubmed-article:10853649pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853649pubmed:citationSubsetIMlld:pubmed
pubmed-article:10853649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853649pubmed:statusMEDLINElld:pubmed
pubmed-article:10853649pubmed:monthMaylld:pubmed
pubmed-article:10853649pubmed:issn0960-894Xlld:pubmed
pubmed-article:10853649pubmed:authorpubmed-author:FillionHHlld:pubmed
pubmed-article:10853649pubmed:authorpubmed-author:PétavyA FAFlld:pubmed
pubmed-article:10853649pubmed:authorpubmed-author:CherkaouiOOlld:pubmed
pubmed-article:10853649pubmed:authorpubmed-author:PautetFFlld:pubmed
pubmed-article:10853649pubmed:authorpubmed-author:SarcironM EMElld:pubmed
pubmed-article:10853649pubmed:authorpubmed-author:WalchshoferNNlld:pubmed
pubmed-article:10853649pubmed:authorpubmed-author:BouammaliBBlld:pubmed
pubmed-article:10853649pubmed:authorpubmed-author:NeboisPPlld:pubmed
pubmed-article:10853649pubmed:authorpubmed-author:BibalBBlld:pubmed
pubmed-article:10853649pubmed:issnTypePrintlld:pubmed
pubmed-article:10853649pubmed:day1lld:pubmed
pubmed-article:10853649pubmed:volume10lld:pubmed
pubmed-article:10853649pubmed:ownerNLMlld:pubmed
pubmed-article:10853649pubmed:authorsCompleteYlld:pubmed
pubmed-article:10853649pubmed:pagination871-3lld:pubmed
pubmed-article:10853649pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10853649pubmed:meshHeadingpubmed-meshheading:10853649...lld:pubmed
pubmed-article:10853649pubmed:meshHeadingpubmed-meshheading:10853649...lld:pubmed
pubmed-article:10853649pubmed:meshHeadingpubmed-meshheading:10853649...lld:pubmed
pubmed-article:10853649pubmed:meshHeadingpubmed-meshheading:10853649...lld:pubmed
pubmed-article:10853649pubmed:meshHeadingpubmed-meshheading:10853649...lld:pubmed
pubmed-article:10853649pubmed:meshHeadingpubmed-meshheading:10853649...lld:pubmed
pubmed-article:10853649pubmed:meshHeadingpubmed-meshheading:10853649...lld:pubmed
pubmed-article:10853649pubmed:meshHeadingpubmed-meshheading:10853649...lld:pubmed
pubmed-article:10853649pubmed:year2000lld:pubmed
pubmed-article:10853649pubmed:articleTitleQuinonic derivatives active against a virulent strain of Toxoplasma gondii. Synthesis of 2-methylfuro[2,3-g]- and [3,2-g]isoquinolinetriones.lld:pubmed
pubmed-article:10853649pubmed:affiliationLaboratoire de Chimie Organique EA 635, Université Claude Bernard, Faculté de Pharmacie, Lyon, France.lld:pubmed
pubmed-article:10853649pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:10853649lld:chembl